SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-15-001099
Filing Date
2015-02-27
Accepted
2015-02-27 16:21:23
Documents
15
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clvs-10k_20141231.htm 10-K 3069841
2 EX-21.1 clvs-ex211_2014123110.htm EX-21.1 4683
3 EX-23.1 clvs-ex231_2014123111.htm EX-23.1 3530
4 EX-31.1 clvs-ex311_201412319.htm EX-31.1 12226
5 EX-31.2 clvs-ex312_201412317.htm EX-31.2 12247
6 EX-32.1 clvs-ex321_201412318.htm EX-32.1 4831
7 EX-32.2 clvs-ex322_201412316.htm EX-32.2 4891
8 GRAPHIC g201502272015273531003.jpg GRAPHIC 107177
9 GRAPHIC g201502272015170401002.jpg GRAPHIC 293362
  Complete submission text file 0001564590-15-001099.txt   15267841

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT clvs-20141231.xml EX-101.INS 2517195
11 XBRL TAXONOMY EXTENSION SCHEMA clvs-20141231.xsd EX-101.SCH 62118
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20141231_cal.xml EX-101.CAL 69656
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20141231_def.xml EX-101.DEF 183066
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20141231_lab.xml EX-101.LAB 483448
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20141231_pre.xml EX-101.PRE 396952
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 15659050
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences